Shilpa Medicare Limited (NSE:SHILPAMED)
India
· Delayed Price · Currency is INR 914.45
+15.75 (1.75%)
Jun 6, 2025, 3:30 PM IST
Shilpa Medicare Revenue
In the fiscal year ending March 31, 2025, Shilpa Medicare had annual revenue of 12.86B INR with 11.56% growth. Shilpa Medicare had revenue of 3.31B in the quarter ending March 31, 2025, with 12.72% growth.
Revenue
12.86B
Revenue Growth
+11.56%
P/S Ratio
6.17
Revenue / Employee
12.77M
Employees
1,007
Market Cap
79.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.86B | 1.33B | 11.56% |
| Mar 31, 2024 | 11.53B | 1.01B | 9.64% |
| Mar 31, 2023 | 10.52B | -952.56M | -8.31% |
| Mar 31, 2022 | 11.47B | 2.45B | 27.21% |
| Mar 31, 2021 | 9.02B | -66.41M | -0.73% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |
Shilpa Medicare News
- 10 days ago - Antique cuts target on Shilpa Medicare to Rs 1,090, retains ‘Buy’ on long-term monetization potential - Business Upturn
- 11 days ago - Top stocks to watch today, May 27: Lupin, Aurobindo Pharma, NHPC, KEC International, Shilpa Medicare and more - Business Upturn
- 15 days ago - Shilpa Medicare subsidiary partners with Orion Corporation to commercialize Recombinant Human Albumin in Europe - Business Upturn
- 23 days ago - Shilpa Medicare shares climb nearly 4% after USFDA EIR for subsidiary, gains European GMP nod for biologics unit - Business Upturn
- 4 weeks ago - Shilpa Medicare’s Bengaluru facility secures GMP approval from EMA for Oral Mouth Dissolving Films and Transdermal Systems - Business Upturn
- 4 weeks ago - Shilpa Medicare shares jump 3% after arm gets EU GMP clearance for Dharwad plant - Business Upturn
- 7 weeks ago - Shilpa Medicare settles Celltrion arbitration case with $3.4 million agreement - Business Upturn
- 2 months ago - Shilpa Medicare gets USFDA approval for Varenicline tablets for smoking cessation - Business Upturn